{"name":"medac GmbH","slug":"medac-gmbh","ticker":"","exchange":"","domain":"medacgmbh.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Busilvex","genericName":"Busilvex","slug":"busilvex","indication":"Allogeneic bone marrow transplantation","status":"phase_2"},{"name":"methotrexate prefilled syringe","genericName":"methotrexate prefilled syringe","slug":"methotrexate-prefilled-syringe","indication":"Rheumatoid arthritis","status":"phase_3"},{"name":"recombinant asparaginase","genericName":"recombinant asparaginase","slug":"recombinant-asparaginase","indication":"Acute lymphoblastic leukemia (ALL)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"MC0518","genericName":"MC0518","slug":"mc0518","indication":"Myelodysplastic syndrome (MDS)","status":"phase_3"}]}],"pipeline":[{"name":"Busilvex","genericName":"Busilvex","slug":"busilvex","phase":"phase_2","mechanism":"Matrix metalloproteinase-9","indications":["Allogeneic bone marrow transplantation","Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","Malignant lymphoma","Neuroblastoma","Philadelphia Chromosome Positive Chronic Myelocytic Leukemia"],"catalyst":""},{"name":"MC0518","genericName":"MC0518","slug":"mc0518","phase":"phase_3","mechanism":"MC0518 is a histone deacetylase (HDAC) inhibitor that promotes differentiation and apoptosis of myelodysplastic syndrome cells.","indications":["Myelodysplastic syndrome (MDS)"],"catalyst":""},{"name":"methotrexate prefilled syringe","genericName":"methotrexate prefilled syringe","slug":"methotrexate-prefilled-syringe","phase":"phase_3","mechanism":"Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, disrupting DNA synthesis and cell division.","indications":["Rheumatoid arthritis","Psoriasis","Breast cancer","Lung cancer","Lymphoma"],"catalyst":""},{"name":"recombinant asparaginase","genericName":"recombinant asparaginase","slug":"recombinant-asparaginase","phase":"marketed","mechanism":"Recombinant asparaginase depletes the amino acid asparagine from the bloodstream, starving asparagine-dependent leukemic cells of an essential nutrient required for protein synthesis.","indications":["Acute lymphoblastic leukemia (ALL)","Acute myeloid leukemia (AML)","Lymphoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1SYnBuSDloOEJzd21xLXg1ZFJ5a0dtWEthX1I4ZXZvaTVLcm1BVDh1UkVNbWd4OWJ2b3NiUzdHUUF0eEs3dXFrQXRjUk00RTctWWNCcDdKTlJWNmFSSmUtZXhUcGt5MXIwS2Q1dDh3V3U?oc=5","date":"2025-08-12","type":"pipeline","source":"Research Nester","summary":"Asparaginase Market Size & Growth Outlook | Forecast to 2035 - Research Nester","headline":"Asparaginase Market Size & Growth Outlook | Forecast to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNWTdhX1lMbXBKaTFMYWwyOGdBeXRrS2hGNzl0LUIxNUZPc3QwMUxFSC0zbzlYcUthYkxoa01ZR3pFdVBTN3ZCTnFUWDUwelJoVk5WNXNKMF9STFF5VWdZUm5oaWI3bDByZ0VfeG1MN0FXTGN3YUR1ZlQ5UE1qZW0yUU4wekxjaUxXWHF6TzFuNlpNV1ZFT3JrX3BsektmS1FUUHNMYnZ6Yl9XczV6UWtjZ2lybVQxS0tNQUV4bGNwczMzeVZZZnozeXkzMXd4em15YlFIVl9RMVlxdnJSS2twNVgyYVViT3cxakl5cWRmS3BmUQ?oc=5","date":"2025-06-12","type":"pipeline","source":"PR Newswire UK","summary":"4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight - PR Newswire UK","headline":"4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQOXFJaGJsVjBjaDRaczRBamphb1BOZ2t2MnZPSWN3c28wOW01SkdHYUNWQ29qWW1NeGhwNmVYdU9IemJNV1Z4RUppTWZwSVRrU3MtTkZSNUhrdzFqQk9zRmhxSWljdTNEQ1NRbzkxVkRjZjJuLWdIZG51amJ1RjZhMklVb3g5MnBHRDF6VFh5bGlQNFFZWmVsSGZ5WlhBb09aYWpRNkdaZ09pZ0pqTmRCNWc4ZHVocVVjanJoc1dsVjkteXFKYTFfZQ?oc=5","date":"2025-05-12","type":"earnings","source":"BioSpace","summary":"UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update - BioSpace","headline":"UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9vTm81UEJ0bGcyNDlpQ0h5SHpZVkpialAxOVZoSkZINmVLdkgtd0RiVGpXNi1UN0dySmZFOTI0UDRPNG1jYlRKN0FnNTAxa0Etd1g0SmhwOHdpcjhJalE?oc=5","date":"2025-02-06","type":"pipeline","source":"UnivDatos","summary":"Asparaginase Market Current Analysis, Size, Share & Forecast 2022-2028 - UnivDatos","headline":"Asparaginase Market Current Analysis, Size, Share & Forecast 2022-2028","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNekhGalZ4RVYtM1Y1YkxzSU5PNGZ3Tmg4MDBRaEtKMkhPOFJiVVRmZ1RoUG1JU29KOTVxZElRS044Ql96WGRwSjBMd2Zjckl0bjZjN1dwTXF0YjhXQWlmQVRjbnc3Yll4S1FjNHFtTUZZMlFHMmVJRHR1QWMyLXVVcWZ0Z1QzVWJGSDd6OUlubDRnTVM5MTY3TzBjRUZQajFoNVFJc08wQTVUTU9HRHhKWDk2VlNwcExjckhTLWNHcWQ?oc=5","date":"2025-01-22","type":"regulatory","source":"Stock Titan","summary":"Medexus Wins FDA Approval for GRAFAPEX Cancer Treatment, Projects $100M Revenue Potential - Stock Titan","headline":"Medexus Wins FDA Approval for GRAFAPEX Cancer Treatment, Projects $100M Revenue Potential","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNSGlRb0hIaFhhYmt1UHhDQUtKRG0zQnFpR3FZN19yb2dLZWxrbHdjcmo2cWZoRDZacXczbzBBTUhPODRHQnU2Tm9YMTVPemVjVVFjY2g5YTh3SkpQLVhFX3NndmdxS1lBWkppeEgwMXNIaUZUeHF4ZnllQmFuMS02RHRjWUI5N1l2Z014bzM0YXpaOW82N0N0ek1tQTI2bDU4bG1mMi1xX3g5RFhhbHBLNEtyM2RTRkw0U1FJNDJQRFNsZ3VmX3JrdkFYcGlTQXpFdEZtSw?oc=5","date":"2024-05-22","type":"pipeline","source":"BioSpectrum Asia","summary":"Metoject subcutaneous injection pen launches in Japan for rheumatic arthritis treatment - BioSpectrum Asia","headline":"Metoject subcutaneous injection pen launches in Japan for rheumatic arthritis treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOSElpeVc2QXR4TE5ZYm5SbVFDYkdfQXhPNDVGSDhjMzVvSXFad1hVckM1Rkx0S1pJb2RPX0hmd0lqczlyY2JGZTVYVmlBZC1fVk1nOFh3R0lUT1BaQm9ZeHJfV1hjY0o4Qy1Pa2w0ODludDg1SERzRnRHclU4YU0wTWh1b0tKbEgyZ3c?oc=5","date":"2024-03-11","type":"pipeline","source":"Yahoo Finance","summary":"medac unveils new Global Corporate Brand - Yahoo Finance","headline":"medac unveils new Global Corporate Brand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPbW5mVUtXYnE4ZTZrWUlTVTFxSDM5N0ROaFE4T1hzRzE1QUdfZU9RZkR4bi1DV0lJY1VIbDZSU1pvMER4X0puNHNxaXh4SExHclJTckZIUGxrbkhoZy1pM0pQdFhZSkdQSXNNQ0JDb3c0VEltRUdVT0JYZUhfYVVsYktXTG5mREhhWkIzMTQ5dmliaWFlaTBGMmt3?oc=5","date":"2024-02-28","type":"pipeline","source":"openPR.com","summary":"Thrombolytic Drug Market Is Booming Worldwide| Medac, Sedico Pharmaceuticals, Eumedica - openPR.com","headline":"Thrombolytic Drug Market Is Booming Worldwide| Medac, Sedico Pharmaceuticals, Eumedica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOalpkMGdHNzY2VnFJakJ5bHZyc0RjWUxKVFp3dTNOZk1NeEVkLVdvOXVvMmt5eFdIeHpnWUVObEIwaEFXRWtlcElMbVB1OTdSODJjSmdaX21UbVpfWF9Cb0M3dEk3OWZlYTNaTFhLYWlybzZudlI2azFLREMtcHoyYnpuZUozUzZoNkE?oc=5","date":"2024-01-17","type":"pipeline","source":"Urology Times","summary":"UGN-103 under development for urothelial cancers - Urology Times","headline":"UGN-103 under development for urothelial cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1NbFZ3eWZUUWhUV0Q1M0RZRnBMMlZ0VUdLbGJ0QTdxVThRaWo1WEhtb0JpdkVucm1TZlk0ZkR6TGl5X0MyVnc2Z091eERRYXBjcmpfUmVWSk5ocjBtTGpn?oc=5","date":"2023-11-04","type":"trial","source":"nature.com","summary":"Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial | Bone Marrow Transplantation - nature.com","headline":"Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOTHRVcHBCWXJDTkhFWXFjV1hNMXo3dXZMTFk1SGktQzRLeWw1OEpzNjdMWTlKVmpna1YxeGxfaURlX3VBNkJzc01mLWhFTDlMQk9GMUtiVEdhQUQ3bkktSWQtTWhjanZ0MlVQeU9WX29wSjMtUTVLRmoyRjkyMmZseFFzS2dpT19adE1PX0FhazkzZ3VtYnlJNy1JSmhVcEhKQnR1bGlQSFJ4YkRobTVUeWJSVnFIU19FekhTVnRad2pOeGdJTml1VG8zOGFMYWpOdkJaNVVMMG9TRnd2eDA0ZlNjSUpsZlZUcmpmVF9NcUtHX0pDdkpST1lDaTEzSzB4Z3phczRpYzdHaTQ4ci00?oc=5","date":"2022-05-03","type":"deal","source":"PR Newswire","summary":"Byondis and medac Enter Into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985) - PR Newswire","headline":"Byondis and medac Enter Into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOaG9fVUJXWW03S2hxZXY4OVBrRUhTMC1kZFV6VnF3UEdEU091U2RQVk9obUlMUGdvWHdmZ0picXZKVjFFUjlmdVZYTTdUTUVLTWhHVkliR0Q2YTV2eVJHZUR0WWxub2cwcVBQSlBMRE8xUmNNc0FZcTZTeURldWdVREdzMWZxMHI3X0lxWFcyb0IzY3VnVk5IdjAwWTk4eUNWODFnY1NNRW1YRVBDb0pBcWIzYUI?oc=5","date":"2022-05-03","type":"deal","source":"Contract Pharma","summary":"Byondis Partners with Medac to Commercialize Antibody-Drug Conjugate - Contract Pharma","headline":"Byondis Partners with Medac to Commercialize Antibody-Drug Conjugate","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_2":1,"phase_3":2,"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}